Sumeet Asrani
Sumeet Asrani
Irritable Bowel Syndrome in Inflammatory Bowel Disease Patients: Prevalence, Etiology, and Treatment [0.03%]
炎症性肠病患者的肠易激综合症：流行率、病因和治疗
David J Gracie,Alexander C Ford
David J Gracie
One in 4 patients with endoscopically confirmed quiescent inflammatory bowel disease (IBD) reports persistent gastrointestinal symptoms, which are often compatible with irritable bowel syndrome (IBS). The reporting of these IBS-type symptom...
Sunny Sandhu,David Goldberg
Sunny Sandhu
Liver transplantation remains a lifesaving intervention for patients with end-stage liver disease; however, organ demand continues to far exceed the supply. The core ethical principles that guide scarce resource allocation include utility, ...
Current Status of Fecal Microbiota Transplantation for Inflammatory Bowel Disease Management [0.03%]
粪便菌群移植在炎症性肠病管理中的现状
Jessica R Allegretti
Jessica R Allegretti
Klaus Mönkemüller
Klaus Mönkemüller
Checkpoint Inhibitor Combinations for Hepatocellular Carcinoma Treatment [0.03%]
肝细胞癌治疗的免疫检查点抑制剂联合疗法
Laura M Kulik
Laura M Kulik
Patient-Provider Conversation About IBS-C Treatment With Tenapanor [0.03%]
关于使用Tenapanor治疗IBS-C的患者与医生对话
Christina Hanson
Christina Hanson